In conclusion, the study has revealed that the epigenetic regulation of KEAP1 expression has different features in KRAS and EGFR settings of NSCLC, suggesting KEAP1 methylation as a predictive marker for response to anti-EGFR agents in oncogene addicted disease. Here, EGFR is linked to non-small cell lung carcinoma.